Phytochemicals Target Multiple Metabolic Pathways in Cancer


Shuvalov O. Kirdeeva Y. Daks A. Fedorova O. Parfenyev S. Simon H.-U. Barlev N.A.
November 2023Multidisciplinary Digital Publishing Institute (MDPI)

Antioxidants
2023#12Issue 11

Cancer metabolic reprogramming is a complex process that provides malignant cells with selective advantages to grow and propagate in the hostile environment created by the immune surveillance of the human organism. This process underpins cancer proliferation, invasion, antioxidant defense, and resistance to anticancer immunity and therapeutics. Perhaps not surprisingly, metabolic rewiring is considered to be one of the “Hallmarks of cancer”. Notably, this process often comprises various complementary and overlapping pathways. Today, it is well known that highly selective inhibition of only one of the pathways in a tumor cell often leads to a limited response and, subsequently, to the emergence of resistance. Therefore, to increase the overall effectiveness of antitumor drugs, it is advisable to use multitarget agents that can simultaneously suppress several key processes in the tumor cell. This review is focused on a group of plant-derived natural compounds that simultaneously target different pathways of cancer-associated metabolism, including aerobic glycolysis, respiration, glutaminolysis, one-carbon metabolism, de novo lipogenesis, and β-oxidation of fatty acids. We discuss only those compounds that display inhibitory activity against several metabolic pathways as well as a number of important signaling pathways in cancer. Information about their pharmacokinetics in animals and humans is also presented. Taken together, a number of known plant-derived compounds may target multiple metabolic and signaling pathways in various malignancies, something that bears great potential for the further improvement of antineoplastic therapy.

cancer metabolism , glutaminolysis , glycolysis , lipid metabolism , metabolic reprogramming and plasticity , multitarget agents , natural compounds , one-carbon metabolism , β-oxidation of fatty acids

Text of the article Перейти на текст статьи

Institute of Cytology of the Russian Academy of Sciences, St. Petersburg, 194064, Russian Federation
Institute of Pharmacology, University of Bern, Bern, 3010, Switzerland
Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, 20000, Kazakhstan

Institute of Cytology of the Russian Academy of Sciences
Institute of Pharmacology
Institute of Fundamental Medicine and Biology
Department of Biomedical Sciences

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026